A multicenter randomized phase II trial of lenvatinib plus everolimus versus cabozantinib in patients with metastatic clear-cell RCC that progressed on PD-1 immune checkpoint inhibition (LenCabo) Article Swipe

PDF

Andrew W. Hahn , Jad Chahoud , William Paul Skelton , Ying Yuan , Amado J. Zurita , C. Kovitz , Omar Alhalabi , Matthew T. Campbell , Eric Jonasch , John K. Lin , Meera Desai , Michael Keith San Diego. Santos , Hyunsoo Hwang , Paul G. Corn , Pavlos Msaouel , Nizar M. Tannir ·

YOU? · · 2025 · Open Access · · DOI: https://doi.org/10.1016/j.annonc.2025.10.009

Related Topics

Delayed Sleep Phase Disorder

Lunar Phase

Phase-Locked Loop

Sublimation (Phase Transition)

Phase 10

In-Phase And Quadrature Components

Phase (Waves)

Randomized Controlled Trial

Phase-Change Material

Solid-Phase Extraction

Phase (Matter)

Phase Noise

Concepts

No concepts available.

Metadata

Type: article
Language: en
Landing Page: https://doi.org/10.1016/j.annonc.2025.10.009
PDF: https://www.annalsofoncology.org/article/S0923-7534(25)04953-1/pdf
OA Status: bronze
References: 29
OpenAlex ID: https://openalex.org/W4415321952

All OpenAlex metadata

Raw OpenAlex JSON

OpenAlex ID: https://openalex.org/W4415321952

Canonical identifier for this work in OpenAlex
DOI: https://doi.org/10.1016/j.annonc.2025.10.009

Digital Object Identifier
Title: A multicenter randomized phase II trial of lenvatinib plus everolimus versus cabozantinib in patients with metastatic clear-cell RCC that progressed on PD-1 immune checkpoint inhibition (LenCabo)

Work title
Type: article

OpenAlex work type
Language: en

Primary language
Publication year: 2025

Year of publication
Publication date: 2025-10-01

Full publication date if available
Authors: Andrew W. Hahn, Jad Chahoud, William Paul Skelton, Ying Yuan, Amado J. Zurita, C. Kovitz, Omar Alhalabi, Matthew T. Campbell, Eric Jonasch, John K. Lin, Meera Desai, Michael Keith San Diego. Santos, Hyunsoo Hwang, Paul G. Corn, Pavlos Msaouel, Nizar M. Tannir

List of authors in order
Landing page: https://doi.org/10.1016/j.annonc.2025.10.009

Publisher landing page
PDF URL: https://www.annalsofoncology.org/article/S0923-7534(25)04953-1/pdf

Direct link to full text PDF
Open access: Yes

Whether a free full text is available
OA status: bronze

Open access status per OpenAlex
OA URL: https://www.annalsofoncology.org/article/S0923-7534(25)04953-1/pdf

Direct OA link when available
Cited by: 0

Total citation count in OpenAlex
References (count): 29

Number of works referenced by this work

Full payload

id	https://openalex.org/W4415321952
doi	https://doi.org/10.1016/j.annonc.2025.10.009
ids.doi	https://doi.org/10.1016/j.annonc.2025.10.009
ids.pmid	https://pubmed.ncbi.nlm.nih.gov/41115467
ids.openalex	https://openalex.org/W4415321952
fwci	0.0
type	article
title	A multicenter randomized phase II trial of lenvatinib plus everolimus versus cabozantinib in patients with metastatic clear-cell RCC that progressed on PD-1 immune checkpoint inhibition (LenCabo)
biblio.issue
biblio.volume
biblio.last_page
biblio.first_page
topics[0].id	https://openalex.org/T10449
topics[0].field.id	https://openalex.org/fields/27
topics[0].field.display_name	Medicine
topics[0].score	0.9998999834060669
topics[0].domain.id	https://openalex.org/domains/4
topics[0].domain.display_name	Health Sciences
topics[0].subfield.id	https://openalex.org/subfields/2740
topics[0].subfield.display_name	Pulmonary and Respiratory Medicine
topics[0].display_name	Renal cell carcinoma treatment
topics[1].id	https://openalex.org/T10158
topics[1].field.id	https://openalex.org/fields/27
topics[1].field.display_name	Medicine
topics[1].score	0.9994999766349792
topics[1].domain.id	https://openalex.org/domains/4
topics[1].domain.display_name	Health Sciences
topics[1].subfield.id	https://openalex.org/subfields/2730
topics[1].subfield.display_name	Oncology
topics[1].display_name	Cancer Immunotherapy and Biomarkers
topics[2].id	https://openalex.org/T10231
topics[2].field.id	https://openalex.org/fields/27
topics[2].field.display_name	Medicine
topics[2].score	0.9991999864578247
topics[2].domain.id	https://openalex.org/domains/4
topics[2].domain.display_name	Health Sciences
topics[2].subfield.id	https://openalex.org/subfields/2730
topics[2].subfield.display_name	Oncology
topics[2].display_name	Pancreatic and Hepatic Oncology Research
is_xpac	False
apc_list.value	4060
apc_list.currency	USD
apc_list.value_usd	4060
apc_paid
language	en
locations[0].id	doi:10.1016/j.annonc.2025.10.009
locations[0].is_oa	True
locations[0].source.id	https://openalex.org/S41454044
locations[0].source.issn	0923-7534, 1569-8041
locations[0].source.type	journal
locations[0].source.is_oa	False
locations[0].source.issn_l	0923-7534
locations[0].source.is_core	True
locations[0].source.is_in_doaj	False
locations[0].source.display_name	Annals of Oncology
locations[0].source.host_organization	https://openalex.org/P4310320990
locations[0].source.host_organization_name	Elsevier BV
locations[0].source.host_organization_lineage	https://openalex.org/P4310320990
locations[0].license
locations[0].pdf_url	https://www.annalsofoncology.org/article/S0923-7534(25)04953-1/pdf
locations[0].version	publishedVersion
locations[0].raw_type	journal-article
locations[0].license_id
locations[0].is_accepted	True
locations[0].is_published	True
locations[0].raw_source_name	Annals of Oncology
locations[0].landing_page_url	https://doi.org/10.1016/j.annonc.2025.10.009
locations[1].id	pmid:41115467
locations[1].is_oa	False
locations[1].source.id	https://openalex.org/S4306525036
locations[1].source.issn
locations[1].source.type	repository
locations[1].source.is_oa	False
locations[1].source.issn_l
locations[1].source.is_core	False
locations[1].source.is_in_doaj	False
locations[1].source.display_name	PubMed
locations[1].source.host_organization	https://openalex.org/I1299303238
locations[1].source.host_organization_name	National Institutes of Health
locations[1].source.host_organization_lineage	https://openalex.org/I1299303238
locations[1].license
locations[1].pdf_url
locations[1].version	publishedVersion
locations[1].raw_type
locations[1].license_id
locations[1].is_accepted	True
locations[1].is_published	True
locations[1].raw_source_name	Annals of oncology : official journal of the European Society for Medical Oncology
locations[1].landing_page_url	https://pubmed.ncbi.nlm.nih.gov/41115467
indexed_in	crossref, pubmed
authorships[0].author.id	https://openalex.org/A5024065466
authorships[0].author.orcid	https://orcid.org/0000-0002-4153-205X
authorships[0].author.display_name	Andrew W. Hahn
authorships[0].countries	US
authorships[0].affiliations[0].institution_ids	https://openalex.org/I1343551460
authorships[0].affiliations[0].raw_affiliation_string	Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: [email protected].
authorships[0].institutions[0].id	https://openalex.org/I1343551460
authorships[0].institutions[0].ror	https://ror.org/04twxam07
authorships[0].institutions[0].type	healthcare
authorships[0].institutions[0].lineage	https://openalex.org/I1343551460
authorships[0].institutions[0].country_code	US
authorships[0].institutions[0].display_name	The University of Texas MD Anderson Cancer Center
authorships[0].author_position	first
authorships[0].raw_author_name	A.W. Hahn
authorships[0].is_corresponding	False
authorships[0].raw_affiliation_strings	Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: [email protected].
authorships[1].author.id	https://openalex.org/A5014154182
authorships[1].author.orcid	https://orcid.org/0000-0002-8435-0264
authorships[1].author.display_name	Jad Chahoud
authorships[1].countries	US
authorships[1].affiliations[0].institution_ids	https://openalex.org/I3019308854
authorships[1].affiliations[0].raw_affiliation_string	Department of Genitourinary Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
authorships[1].institutions[0].id	https://openalex.org/I3019308854
authorships[1].institutions[0].ror	https://ror.org/01xf75524
authorships[1].institutions[0].type	healthcare
authorships[1].institutions[0].lineage	https://openalex.org/I3019308854
authorships[1].institutions[0].country_code	US
authorships[1].institutions[0].display_name	Moffitt Cancer Center
authorships[1].author_position	middle
authorships[1].raw_author_name	J. Chahoud
authorships[1].is_corresponding	False
authorships[1].raw_affiliation_strings	Department of Genitourinary Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
authorships[2].author.id	https://openalex.org/A5058250570
authorships[2].author.orcid	https://orcid.org/0000-0003-4923-8178
authorships[2].author.display_name	William Paul Skelton
authorships[2].countries	US
authorships[2].affiliations[0].institution_ids	https://openalex.org/I1343551460, https://openalex.org/I51556381
authorships[2].affiliations[0].raw_affiliation_string	Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Division of Hematology and Oncology, University of Virginia, Charlottesville, VA, USA.
authorships[2].institutions[0].id	https://openalex.org/I1343551460
authorships[2].institutions[0].ror	https://ror.org/04twxam07
authorships[2].institutions[0].type	healthcare
authorships[2].institutions[0].lineage	https://openalex.org/I1343551460
authorships[2].institutions[0].country_code	US
authorships[2].institutions[0].display_name	The University of Texas MD Anderson Cancer Center
authorships[2].institutions[1].id	https://openalex.org/I51556381
authorships[2].institutions[1].ror	https://ror.org/0153tk833
authorships[2].institutions[1].type	education
authorships[2].institutions[1].lineage	https://openalex.org/I51556381
authorships[2].institutions[1].country_code	US
authorships[2].institutions[1].display_name	University of Virginia
authorships[2].author_position	middle
authorships[2].raw_author_name	W.P. Skelton
authorships[2].is_corresponding	False
authorships[2].raw_affiliation_strings	Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Division of Hematology and Oncology, University of Virginia, Charlottesville, VA, USA.
authorships[3].author.id	https://openalex.org/A5040527192
authorships[3].author.orcid	https://orcid.org/0000-0002-3922-9553
authorships[3].author.display_name	Ying Yuan
authorships[3].countries	US
authorships[3].affiliations[0].institution_ids	https://openalex.org/I1343551460
authorships[3].affiliations[0].raw_affiliation_string	Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
authorships[3].institutions[0].id	https://openalex.org/I1343551460
authorships[3].institutions[0].ror	https://ror.org/04twxam07
authorships[3].institutions[0].type	healthcare
authorships[3].institutions[0].lineage	https://openalex.org/I1343551460
authorships[3].institutions[0].country_code	US
authorships[3].institutions[0].display_name	The University of Texas MD Anderson Cancer Center
authorships[3].author_position	middle
authorships[3].raw_author_name	Y. Yuan
authorships[3].is_corresponding	False
authorships[3].raw_affiliation_strings	Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
authorships[4].author.id	https://openalex.org/A5059272502
authorships[4].author.orcid	https://orcid.org/0000-0002-3805-7307
authorships[4].author.display_name	Amado J. Zurita
authorships[4].countries	US
authorships[4].affiliations[0].institution_ids	https://openalex.org/I1343551460
authorships[4].affiliations[0].raw_affiliation_string	Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
authorships[4].institutions[0].id	https://openalex.org/I1343551460
authorships[4].institutions[0].ror	https://ror.org/04twxam07
authorships[4].institutions[0].type	healthcare
authorships[4].institutions[0].lineage	https://openalex.org/I1343551460
authorships[4].institutions[0].country_code	US
authorships[4].institutions[0].display_name	The University of Texas MD Anderson Cancer Center
authorships[4].author_position	middle
authorships[4].raw_author_name	A.J. Zurita
authorships[4].is_corresponding	False
authorships[4].raw_affiliation_strings	Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
authorships[5].author.id	https://openalex.org/A5066098055
authorships[5].author.orcid
authorships[5].author.display_name	C. Kovitz
authorships[5].countries	US
authorships[5].affiliations[0].institution_ids	https://openalex.org/I1343551460
authorships[5].affiliations[0].raw_affiliation_string	Department of General Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
authorships[5].institutions[0].id	https://openalex.org/I1343551460
authorships[5].institutions[0].ror	https://ror.org/04twxam07
authorships[5].institutions[0].type	healthcare
authorships[5].institutions[0].lineage	https://openalex.org/I1343551460
authorships[5].institutions[0].country_code	US
authorships[5].institutions[0].display_name	The University of Texas MD Anderson Cancer Center
authorships[5].author_position	middle
authorships[5].raw_author_name	C. Kovitz
authorships[5].is_corresponding	False
authorships[5].raw_affiliation_strings	Department of General Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
authorships[6].author.id	https://openalex.org/A5003873827
authorships[6].author.orcid	https://orcid.org/0000-0002-9658-2206
authorships[6].author.display_name	Omar Alhalabi
authorships[6].countries	US
authorships[6].affiliations[0].institution_ids	https://openalex.org/I1343551460
authorships[6].affiliations[0].raw_affiliation_string	Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
authorships[6].institutions[0].id	https://openalex.org/I1343551460
authorships[6].institutions[0].ror	https://ror.org/04twxam07
authorships[6].institutions[0].type	healthcare
authorships[6].institutions[0].lineage	https://openalex.org/I1343551460
authorships[6].institutions[0].country_code	US
authorships[6].institutions[0].display_name	The University of Texas MD Anderson Cancer Center
authorships[6].author_position	middle
authorships[6].raw_author_name	O. Alhalabi
authorships[6].is_corresponding	False
authorships[6].raw_affiliation_strings	Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
authorships[7].author.id	https://openalex.org/A5008861348
authorships[7].author.orcid	https://orcid.org/0000-0003-1915-4491
authorships[7].author.display_name	Matthew T. Campbell
authorships[7].countries	US
authorships[7].affiliations[0].institution_ids	https://openalex.org/I1343551460
authorships[7].affiliations[0].raw_affiliation_string	Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
authorships[7].institutions[0].id	https://openalex.org/I1343551460
authorships[7].institutions[0].ror	https://ror.org/04twxam07
authorships[7].institutions[0].type	healthcare
authorships[7].institutions[0].lineage	https://openalex.org/I1343551460
authorships[7].institutions[0].country_code	US
authorships[7].institutions[0].display_name	The University of Texas MD Anderson Cancer Center
authorships[7].author_position	middle
authorships[7].raw_author_name	M.T. Campbell
authorships[7].is_corresponding	False
authorships[7].raw_affiliation_strings	Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
authorships[8].author.id	https://openalex.org/A5007689146
authorships[8].author.orcid	https://orcid.org/0000-0003-0943-2806
authorships[8].author.display_name	Eric Jonasch
authorships[8].countries	US
authorships[8].affiliations[0].institution_ids	https://openalex.org/I1343551460
authorships[8].affiliations[0].raw_affiliation_string	Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
authorships[8].institutions[0].id	https://openalex.org/I1343551460
authorships[8].institutions[0].ror	https://ror.org/04twxam07
authorships[8].institutions[0].type	healthcare
authorships[8].institutions[0].lineage	https://openalex.org/I1343551460
authorships[8].institutions[0].country_code	US
authorships[8].institutions[0].display_name	The University of Texas MD Anderson Cancer Center
authorships[8].author_position	middle
authorships[8].raw_author_name	E. Jonasch
authorships[8].is_corresponding	False
authorships[8].raw_affiliation_strings	Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
authorships[9].author.id	https://openalex.org/A5036072791
authorships[9].author.orcid	https://orcid.org/0000-0003-2490-4453
authorships[9].author.display_name	John K. Lin
authorships[9].countries	US
authorships[9].affiliations[0].institution_ids	https://openalex.org/I1343551460
authorships[9].affiliations[0].raw_affiliation_string	Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
authorships[9].institutions[0].id	https://openalex.org/I1343551460
authorships[9].institutions[0].ror	https://ror.org/04twxam07
authorships[9].institutions[0].type	healthcare
authorships[9].institutions[0].lineage	https://openalex.org/I1343551460
authorships[9].institutions[0].country_code	US
authorships[9].institutions[0].display_name	The University of Texas MD Anderson Cancer Center
authorships[9].author_position	middle
authorships[9].raw_author_name	J. Lin
authorships[9].is_corresponding	False
authorships[9].raw_affiliation_strings	Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
authorships[10].author.id	https://openalex.org/A5085949327
authorships[10].author.orcid
authorships[10].author.display_name	Meera Desai
authorships[10].countries	US
authorships[10].affiliations[0].institution_ids	https://openalex.org/I1343551460
authorships[10].affiliations[0].raw_affiliation_string	Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
authorships[10].institutions[0].id	https://openalex.org/I1343551460
authorships[10].institutions[0].ror	https://ror.org/04twxam07
authorships[10].institutions[0].type	healthcare
authorships[10].institutions[0].lineage	https://openalex.org/I1343551460
authorships[10].institutions[0].country_code	US
authorships[10].institutions[0].display_name	The University of Texas MD Anderson Cancer Center
authorships[10].author_position	middle
authorships[10].raw_author_name	M. Desai
authorships[10].is_corresponding	False
authorships[10].raw_affiliation_strings	Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
authorships[11].author.id	https://openalex.org/A5069346481
authorships[11].author.orcid
authorships[11].author.display_name	Michael Keith San Diego. Santos
authorships[11].countries	US
authorships[11].affiliations[0].institution_ids	https://openalex.org/I1343551460
authorships[11].affiliations[0].raw_affiliation_string	Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
authorships[11].institutions[0].id	https://openalex.org/I1343551460
authorships[11].institutions[0].ror	https://ror.org/04twxam07
authorships[11].institutions[0].type	healthcare
authorships[11].institutions[0].lineage	https://openalex.org/I1343551460
authorships[11].institutions[0].country_code	US
authorships[11].institutions[0].display_name	The University of Texas MD Anderson Cancer Center
authorships[11].author_position	middle
authorships[11].raw_author_name	M.J.M.N. Santos
authorships[11].is_corresponding	False
authorships[11].raw_affiliation_strings	Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
authorships[12].author.id	https://openalex.org/A5085348528
authorships[12].author.orcid	https://orcid.org/0000-0003-0308-5145
authorships[12].author.display_name	Hyunsoo Hwang
authorships[12].countries	US
authorships[12].affiliations[0].institution_ids	https://openalex.org/I1343551460
authorships[12].affiliations[0].raw_affiliation_string	Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
authorships[12].institutions[0].id	https://openalex.org/I1343551460
authorships[12].institutions[0].ror	https://ror.org/04twxam07
authorships[12].institutions[0].type	healthcare
authorships[12].institutions[0].lineage	https://openalex.org/I1343551460
authorships[12].institutions[0].country_code	US
authorships[12].institutions[0].display_name	The University of Texas MD Anderson Cancer Center
authorships[12].author_position	middle
authorships[12].raw_author_name	H. Hwang
authorships[12].is_corresponding	False
authorships[12].raw_affiliation_strings	Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
authorships[13].author.id	https://openalex.org/A5062740919
authorships[13].author.orcid	https://orcid.org/0000-0002-4106-6335
authorships[13].author.display_name	Paul G. Corn
authorships[13].countries	US
authorships[13].affiliations[0].institution_ids	https://openalex.org/I1343551460
authorships[13].affiliations[0].raw_affiliation_string	Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
authorships[13].institutions[0].id	https://openalex.org/I1343551460
authorships[13].institutions[0].ror	https://ror.org/04twxam07
authorships[13].institutions[0].type	healthcare
authorships[13].institutions[0].lineage	https://openalex.org/I1343551460
authorships[13].institutions[0].country_code	US
authorships[13].institutions[0].display_name	The University of Texas MD Anderson Cancer Center
authorships[13].author_position	middle
authorships[13].raw_author_name	P.G. Corn
authorships[13].is_corresponding	False
authorships[13].raw_affiliation_strings	Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
authorships[14].author.id	https://openalex.org/A5080220488
authorships[14].author.orcid	https://orcid.org/0000-0001-6505-8308
authorships[14].author.display_name	Pavlos Msaouel
authorships[14].countries	US
authorships[14].affiliations[0].institution_ids	https://openalex.org/I1343551460, https://openalex.org/I919571938
authorships[14].affiliations[0].raw_affiliation_string	Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences (GSBS), Houston, TX 77030, USA. Electronic address: [email protected].
authorships[14].institutions[0].id	https://openalex.org/I919571938
authorships[14].institutions[0].ror	https://ror.org/03gds6c39
authorships[14].institutions[0].type	education
authorships[14].institutions[0].lineage	https://openalex.org/I919571938
authorships[14].institutions[0].country_code	US
authorships[14].institutions[0].display_name	The University of Texas Health Science Center at Houston
authorships[14].institutions[1].id	https://openalex.org/I1343551460
authorships[14].institutions[1].ror	https://ror.org/04twxam07
authorships[14].institutions[1].type	healthcare
authorships[14].institutions[1].lineage	https://openalex.org/I1343551460
authorships[14].institutions[1].country_code	US
authorships[14].institutions[1].display_name	The University of Texas MD Anderson Cancer Center
authorships[14].author_position	middle
authorships[14].raw_author_name	P. Msaouel
authorships[14].is_corresponding	False
authorships[14].raw_affiliation_strings	Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences (GSBS), Houston, TX 77030, USA. Electronic address: [email protected].
authorships[15].author.id	https://openalex.org/A5058115259
authorships[15].author.orcid	https://orcid.org/0000-0001-5559-8060
authorships[15].author.display_name	Nizar M. Tannir
authorships[15].countries	US
authorships[15].affiliations[0].institution_ids	https://openalex.org/I1343551460
authorships[15].affiliations[0].raw_affiliation_string	Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: [email protected].
authorships[15].institutions[0].id	https://openalex.org/I1343551460
authorships[15].institutions[0].ror	https://ror.org/04twxam07
authorships[15].institutions[0].type	healthcare
authorships[15].institutions[0].lineage	https://openalex.org/I1343551460
authorships[15].institutions[0].country_code	US
authorships[15].institutions[0].display_name	The University of Texas MD Anderson Cancer Center
authorships[15].author_position	last
authorships[15].raw_author_name	N.M. Tannir
authorships[15].is_corresponding	False
authorships[15].raw_affiliation_strings	Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: [email protected].
has_content.pdf	True
has_content.grobid_xml	False
is_paratext	False
open_access.is_oa	True
open_access.oa_url	https://www.annalsofoncology.org/article/S0923-7534(25)04953-1/pdf
open_access.oa_status	bronze
open_access.any_repository_has_fulltext	False
created_date	2025-10-19T00:00:00
display_name	A multicenter randomized phase II trial of lenvatinib plus everolimus versus cabozantinib in patients with metastatic clear-cell RCC that progressed on PD-1 immune checkpoint inhibition (LenCabo)
has_fulltext	False
is_retracted	False
updated_date	2025-11-23T05:10:03.516525
primary_topic.id	https://openalex.org/T10449
primary_topic.field.id	https://openalex.org/fields/27
primary_topic.field.display_name	Medicine
primary_topic.score	0.9998999834060669
primary_topic.domain.id	https://openalex.org/domains/4
primary_topic.domain.display_name	Health Sciences
primary_topic.subfield.id	https://openalex.org/subfields/2740
primary_topic.subfield.display_name	Pulmonary and Respiratory Medicine
primary_topic.display_name	Renal cell carcinoma treatment
cited_by_count	0
locations_count	2
best_oa_location.id	doi:10.1016/j.annonc.2025.10.009
best_oa_location.is_oa	True
best_oa_location.source.id	https://openalex.org/S41454044
best_oa_location.source.issn	0923-7534, 1569-8041
best_oa_location.source.type	journal
best_oa_location.source.is_oa	False
best_oa_location.source.issn_l	0923-7534
best_oa_location.source.is_core	True
best_oa_location.source.is_in_doaj	False
best_oa_location.source.display_name	Annals of Oncology
best_oa_location.source.host_organization	https://openalex.org/P4310320990
best_oa_location.source.host_organization_name	Elsevier BV
best_oa_location.source.host_organization_lineage	https://openalex.org/P4310320990
best_oa_location.license
best_oa_location.pdf_url	https://www.annalsofoncology.org/article/S0923-7534(25)04953-1/pdf
best_oa_location.version	publishedVersion
best_oa_location.raw_type	journal-article
best_oa_location.license_id
best_oa_location.is_accepted	True
best_oa_location.is_published	True
best_oa_location.raw_source_name	Annals of Oncology
best_oa_location.landing_page_url	https://doi.org/10.1016/j.annonc.2025.10.009
primary_location.id	doi:10.1016/j.annonc.2025.10.009
primary_location.is_oa	True
primary_location.source.id	https://openalex.org/S41454044
primary_location.source.issn	0923-7534, 1569-8041
primary_location.source.type	journal
primary_location.source.is_oa	False
primary_location.source.issn_l	0923-7534
primary_location.source.is_core	True
primary_location.source.is_in_doaj	False
primary_location.source.display_name	Annals of Oncology
primary_location.source.host_organization	https://openalex.org/P4310320990
primary_location.source.host_organization_name	Elsevier BV
primary_location.source.host_organization_lineage	https://openalex.org/P4310320990
primary_location.license
primary_location.pdf_url	https://www.annalsofoncology.org/article/S0923-7534(25)04953-1/pdf
primary_location.version	publishedVersion
primary_location.raw_type	journal-article
primary_location.license_id
primary_location.is_accepted	True
primary_location.is_published	True
primary_location.raw_source_name	Annals of Oncology
primary_location.landing_page_url	https://doi.org/10.1016/j.annonc.2025.10.009
publication_date	2025-10-01
publication_year	2025
referenced_works	https://openalex.org/W3200844743, https://openalex.org/W4401305294, https://openalex.org/W4412819491, https://openalex.org/W4391303247, https://openalex.org/W4390902638, https://openalex.org/W4379389239, https://openalex.org/W4402518174, https://openalex.org/W2134131507, https://openalex.org/W2206853573, https://openalex.org/W2237254160, https://openalex.org/W2415950182, https://openalex.org/W4390345332, https://openalex.org/W4381492336, https://openalex.org/W4404086900, https://openalex.org/W4381492330, https://openalex.org/W2113322173, https://openalex.org/W3033487843, https://openalex.org/W4410821487, https://openalex.org/W2433976232, https://openalex.org/W4398213922, https://openalex.org/W4213178408, https://openalex.org/W4294000513, https://openalex.org/W4319460485, https://openalex.org/W4309409970, https://openalex.org/W3193770068, https://openalex.org/W4386963006, https://openalex.org/W4389954897, https://openalex.org/W4402975349, https://openalex.org/W4404119826
referenced_works_count	29
abstract_inverted_index
cited_by_percentile_year
countries_distinct_count	1
institutions_distinct_count	16
citation_normalized_percentile.value	0.6563951
citation_normalized_percentile.is_in_top_1_percent	False
citation_normalized_percentile.is_in_top_10_percent	False